Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00742586 · ClinicalTrials.gov registry record

Autonomic Failure Patients for RNA Blood Sampling

A clinical trial, sponsored by Vanderbilt University.

Completed
Registry status
30
Enrollment target

NCT00742586: Completed study, sponsored by Vanderbilt University.

NCT00742586 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00742586 has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

The purpose of this study is to identify 15 patients with autonomic failure and obtain blood samples for RNA from those participants and 15 control subjects within the same age range. The stabilized blood samples, along with a limited data set, will be shipped to Western Michigan University where the actual laboratory analysis (a separate study) of the samples will take place. Unique genetic inscriptions, called gene expression signatures, are currently being identified for many diseases, including neurological diseases. The secondary goal of this study is to support the research being done at WMU and they try to look for MSA-specific signs are present in whole blood samples of MSA patients at late-stages of the disease. This is a pilot study that has a long term goal (through additional studies) a MSA-specific gene expression signature for the development of a diagnostic test for this disease that can be used in the future. Other patient groups with autonomic failure, characterized by significant drop in blood pressure on standing, will also be included in this study, to look for similar genetic inscriptions. This pilot study is expected to last for 2 years. The investigators at WMU will need some de-identified health Information about the subjects, including their age at diagnosis, age (when sample drawn) and list of their medications

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-07
Est. Completion 2009-02
Vanderbilt University

430 total trials

What the finished NCT00742586 record still lists

NCT00742586 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00742586 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00742586 about?

NCT00742586 is a clinical study titled "Autonomic Failure Patients for RNA Blood Sampling". The purpose of this study is to identify 15 patients with autonomic failure and obtain blood samples for RNA from those participants and 15 control subjects within the same age range. The stabilized blood samples, along with a limited data set, will be shipped to Western Michigan University where th...

What is the current status of trial NCT00742586?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-07. Estimated completion is 2009-02.

Who is sponsoring clinical trial NCT00742586?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00742586, the US trial registry maintained by the National Library of Medicine. NCT00742586 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.